Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR), a specialty pharmaceutical company, is committed to providing prescription drugs designed to address central nervous system (CNS) disorders. Currently, the company is building a core portfolio of both marketed and development-stage products that attend to substantial, but unmet medical needs. Questcor’s aim is to develop and commercialize their own proprietary products, while staying open to partnering concepts to leverage assets and further build its portfolio. For further information, visit the Company’s web site at www.questcor.com.
- 17 years ago
QualityStocks
Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Leveraging MCO Success to Elevate Portfolio Clubs to the International Stage
Brera Holdings (NASDAQ: BREA), an Ireland-based company focused on expanding a global portfolio of men’s…
-
QualityStocksNewsBreaks – Why Silvercorp Metals Inc. (NYSE American: SVM) (TSX: SVM) Is ‘One to Watch’
Silvercorp Metals (NYSE American: SVM) (TSX: SVM) is a Canadian mining company with a strong track…
-
Nutriband Inc. (NASDAQ: NTRB) Reimagining Drug Safety Through Scalable Innovation
Nutriband Inc. has been granted a new U.S. patent for its AVERSA(TM) transdermal abuse-deterrent technology,…